A Prospective Randomised Open Label Trial of Oxaliplatin/Fluoropyrimidine Versus Oxaliplatin/Fluoropyrimidine Plus Cetuximab Pre and Post Operatively in Patients With Resectable Colorectal Liver Metastasis Requiring Chemotherapy
Phase of Trial: Phase III
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Cetuximab (Primary) ; Capecitabine; Fluorouracil; Folinic acid; Irinotecan; Oxaliplatin
- Indications Colorectal cancer; Liver metastases
- Focus Therapeutic Use
- Acronyms New-EPOC
- 19 Jul 2016 Results published in the British Journal of Cancer (2016).
- 01 Jun 2015 According to an IntegraGen media release, data from this study were presented at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting.
- 30 Aug 2014 Accrual to date is 100% according to United Kingdom Clinical Research Network record.